Evaluation of Anti-SARS-Cov-2 S-RBD IgG Antibodies after COVID-19 mRNA BNT162b2 Vaccine

Evaluation of Anti-SARS-Cov-2 S-RBD IgG Antibodies after COVID-19 mRNA BNT162b2 Vaccine

(1) Background: The evaluation of anti-spike protein receptor-binding domain (S-RBD) antibodies represents a useful tool to estimate the individual protection against Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2) infection; (2) Methods: We evaluated anti S-RBD IgG levels by indirect c...

Full description

Bibliographic Details
Main Authors: Bruna Lo Sasso, Rosaria Vincenza Giglio, Matteo Vidali, Concetta Scazzone, Giulia Bivona, Caterina Maria Gambino, Anna Maria Ciaccio, Luisa Agnello, Marcello Ciaccio
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Diagnostics
Subjects:
antibodies
COVID-19
immunosurvelliance
SARS-CoV-2
S-RBD IgG
spike
Online Access:https://www.mdpi.com/2075-4418/11/7/1135

Internet

https://www.mdpi.com/2075-4418/11/7/1135

Similar Items